Anthera Pharmaceuticals. Inc.
Q3 2017 13F Holders
Symbol
ANTH
CUSIP
03674U300
Type
Equity
Class
COM
Num filings
37
Total reported value, excl. options
$3.21 M
Compare 2017 Q3 to
2019 Q4
2018 Q3
2018 Q2
2018 Q1
2017 Q4
2017 Q2
2017 Q1
Manager
Report Date
Value ($000)
Shares
Option Type